Advocacy intelligence hub — real-time data for patient organizations
University Hospital, Toulouse — PHASE2
Huashan Hospital — PHASE1
Xuanwu Hospital, Beijing — PHASE1, PHASE2
Arialys Australia Pty Ltd — PHASE2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Arialys Therapeutics — PHASE1
Xijing Hospital — NA
Xuanwu Hospital, Beijing
Xuanwu Hospital, Beijing
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Raffaele Iorio
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Jérôme HONNORAT, MD
Centre de référence des syndromes neurologies paranéoplasiques et encéphalites auto-immunes - Hôpital neurologiques Pierre WERTHEIMER - Groupement hospitalier Est - Hospices civiles de Lyon
Chunhong Shen
Second Affiliated Hospital, School of Medicine, Zhejiang University
Dai-shi Tian, MD
Tongji Hospital
Stacey L Clardy, MD, PhD
University of Utah
📍 Birmingham, Alabama
Anna Rostedt Punga, Professor
Uppsala University